OxyWatch Pulse Oximeter MD300C63

Added Jan 31, 2013

Manufactured by Choicemmed

Editor Rating

info

User Rating

info
Add your Rating

Description

From Which Medical Device

The OxyWatch Pulse Oximeter MD300C63 is a non-invasive device for monitoring a patient's heart rate and blood oxygen level. It is suitable for use with adults, children and infants.

The device has FDA, CE, PMDA (Japan), CMDCAS (Canada), Certification.

 _________________________________________________________________________________________________________________________________________________________________________

Which Medical Device of the Year 2012

Runner-up: Anaesthesia

 

Our nominator said, "...I find myself using this oximeter more than any other piece of kit I carry when I'm undertaking my work in the Pre-Hospital environment."

We say, "...a device that can be widely used in almost any emergency situation quickly giving a reliable measurement of the patients pulse and oxygenation."

Read the full list of Which Medical Device of the Year 2012 winners here

Have you used this device?

Your opinion matters to others - rate this device or add a comment

Similar Devices

  • 1-2
  • of
  • 2

WhichMedicalDevice is a FREE resource created by clinicians for clinicians.

Registration is free and gives you unlimited access to all of the content and features of this website.

Find out more...

Please sign in to view this content...

I have forgotten my password
Not a Member?

Registration is free and gives you unlimited access to all of the content and features of Which Medical Device. Find out more...

Why Register

Which Medical Device is a community of clinicians sharing knowledge and experience of the devices and procedures we use on a daily basis. We ask that our members register with us so that we can maintain the unbiased and independent nature of our content. Registration is quick and free.

We do not make your details available to any third parties nor do we send unsolicited emails to our members. You can read our Privacy Policy here.